155412-88-7 ((CCK-B Receptor Antagonist 2)

Urea,N-(3-aminophenyl)-N'-[1-(3,3-dimethyl-2-oxobutyl)-2,3-dihydro-2-oxo-5-(2-pyridinyl)-1H-1,4-benzodiazepin-3-yl]-, (R)-;CCK-B Receptor Antagonist 2;BDBM50056086;PDSP1_000894;PDSP2_000880;(R)-1-(3-Aminophenyl)-3-(1-(3,3-dimethyl-2-oxobutyl)-2-oxo-5-(pyridin-2-yl)-2,3-dihydro-1H-benzo[e][1,4]diazepin-3-yl)urea;1-(3-Amino-phenyl)-3-[(R)-1-(3,3-dimethyl-2-oxo-butyl)-2-oxo-5-pyridin-2-yl-2,3-dihydro-1H-benzo[e][1,4]diazepin-3-yl]-urea;1-(3-aminophenyl)-3-[(3R)-1-(3,3-dimethyl-2-oxobutyl)-2-oxo-5-pyridin-2-yl-3H-1,4-benzodiazepin-3-yl]urea;155412-88-7;G17315;AKOS040732738;CHEMBL115612;SCHEMBL1389112;CS-0104987;DA-62123;MS-29006;HY-129357;

ABJHMASUFPDZRW-DEOSSOPVSA-N

1S/C27H28N6O3/c1-27(2,3)22(34)16-33-21-13-5-4-11-19(21)23(20-12-6-7-14-29-20)31-24(25(33)35)32-26(36)30-18-10-8-9-17(28)15-18/h4-15,24H,16,28H2,1-3H3,(H2,30,32,36)/t24-/m0/s1

O=C(CN1C([C@H](NC(NC2C=CC=C(C=2)N)=O)N=C(C2C=CC=CN=2)C2C=CC=CC1=2)=O)C(C)(C)C